Here are what the editors at HealthDay consider to be the most important developments in Cardiology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
ATS Issues Practice Guideline for Pediatric Home Oxygen Therapy
THURSDAY, Feb. 28, 2019 (HealthDay News) — Recommendations have been developed for home oxygen therapy in children with chronic respiratory conditions; the clinical practice guideline from the American Thoracic Society was published in the Feb. 1 issue of the American Journal of Respiratory and Critical Care Medicine.
Advanced Echocardiographic Training Requirements Issued
THURSDAY, Feb. 28, 2019 (HealthDay News) — The training requirements for performing advanced echocardiographic procedures (Level III training) are discussed in a statement from the American College of Cardiology, the American Heart Association, and the American Society of Echocardiography; the report was published online Feb. 19 in the Journal of the American College of Cardiology.
HEART Care Pathway Reduces Admission, Stress Testing in ACS
THURSDAY, Feb. 28, 2019 (HealthDay News) — Implementing a history, electrocardiogram, age, risk factors, and troponin (HEART) care pathway can reduce use of hospital care and noninvasive stress testing among patients with suspected acute coronary syndrome (ACS), according to a study published online Feb. 20 in the Annals of Emergency Medicine.
Lowering BP, Lipids in Healthy Elderly Has No Cognitive Effect
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — Candesartan plus hydrochlorothiazide, rosuvastatin, or their combination do not impact cognitive decline among older people, according to a study published online Feb. 27 in Neurology.
Achievement of Targets in T2DM Varies by Season
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — There is seasonal variation in achievement of the guideline targets for hemoglobin A1c (HbA1c), blood pressure (BP), and low-density lipoprotein (LDL) cholesterol among persons with type 2 diabetes mellitus (T2DM), according to a study published online Feb. 22 in Diabetes Care.
Kidney Disease Affects Revascularization Outcomes
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — The presence of comorbid chronic kidney disease (CKD) negatively impacts myocardial revascularization outcomes in patients with type 2 diabetes mellitus (T2DM), according to a study published in the Feb. 5 issue of the Journal of the American College of Cardiology.
MRI Cardiac Stress Test Predicts Death From Heart Disease